Saturday, 20 April 2024

 

 

LATEST NEWS CGC Jhanjeri’s Fashion Show MERAKI 2024 goes in Style CEO Maneesh Garg briefs about Postal ballot facility for absentee voters Alumnus Sh. Ram Kumar Mittal, Founder & President of Swami International, USA, Inspires Students During Campus Visit to PEC In a first, CEO Sibin C holds Facebook live interaction with Punjab voters Top 9 Monalisa Hot Web Series To Watch In April 2024 | 5 Dariya News Drug awareness rally under NSS camp by RBU students Wheat planted using surface feeders at 40 places in barnala district : Punamdeep Kaur NSS PEC Organized Blood Donation Camp in Collaboration with PGIMER Biomed lab science day celebrated at RBU Singer Javed Ali recorded the song for Speed India Entertainment & HGV Anup Jalota, Udit Narayan, Babul Supriyo, and other singers received Dr. K.J. Yesudas Achievement Award Unique Initiative: Punjab's CEO Sibin C to go live on Facebook on April 19th Special monitoring of Social Media for Model Code of Conduct compliance - Chief Electoral Officer Anurag Agarwal In unique initiative, administration launches video helpline number 83605-83697 for speech and hearing-impaired voters Sakshi Sawhney directs procurement agencies to expedite wheat lifting Will make Punjabi the number one language in Chandigarh - Sanjay Tandon Vigilance Bureau nabs ASI for accepting Rs 4,500 bribe Magnificent Display of Indian Culture at LPU's annual 'One India-2024' Cultural Fest Suzuki Motorcycle India expands its footprint in Kerala Unlike Ravneet Bittu, Congress Has Always Respected Beant Singh Ji’s Legacy: Amarinder Singh Raja Warring Kunwar Vijay Pratap's speech should be taken seriously and investigation should be conducted: Partap Singh Bajwa

 

New antiplatelet drug shows promise for treating heart attack

Listen to this article

Web Admin

Web Admin

5 Dariya News

New York , 16 Jul 2020

Researchers have developed a new drug that prevents blood clots without causing an increased risk of bleeding, a common side effect of all antiplatelet medications currently available.The study, published in the journal Science Translational Medicine, described the drug and its delivery mechanisms and shows that the drug is also an effective treatment for heart attack in animal models."Unfortunately, current antiplatelet medications prevent the blood clotting that causes heart attack and stroke but also disrupt platelets' ability to stop bleeding if a blood vessel is torn," said study researcher Xiaoping Du from the University of Illinois in the US."The magic of this new drug is it prevents clots but does not make people prone to bleeding, which other drugs have failed to do," Du added.In a previous study, the research team identified a signalling mechanism that is important in the blood clotting process but not required for platelets' ability to adhere to a wound and prevent bleeding. Based on this finding, the researchers derived a peptide to target the signalling mechanism and designed a nanoparticle that successfully delivered the peptide into platelets.The peptide-derived nanoparticle drug -- called M3mP6 high-loading peptide nanoparticle, of HLPN -- was then tested in mice as a possible treatment for heart attacks.

Du said a heart attack can cause heart failure and death in two different ways. One, from the initial damage caused by the clot, which blocks blood flow and reduces oxygen supply.This typically is treated by a procedure called angioplasty and a stent to open the artery, combined with antiplatelet drugs to prevent it from clotting again. However, fresh blood flowing into the damaged heart tissue following the reopening of the artery can trigger inflammation, causing leaks and clots in small blood vessels and further damage to the heart, the researchers said."This is called reperfusion injury and this is the second way a heart attack can lead to heart failure or death," Du said. In the study, among mice that received the treatment, administered as an injection, there was reduced damage to the heart, reduced clotting and reduced inflammation. There also was improved heart function and improved survival."It is very exciting to see such promising results in the lab and we hope to one day test this in humans," Du said. "We were hopeful that this new drug, which does not cause blood vessel leaks, would help limit reperfusion injury and reduce the chance of heart failure and death," the study authors wrote.

 

Tags: Health , Study , Research , Researcher , New York , Heart attack , Drug , World News

 

 

related news

 

 

 

Photo Gallery

 

 

Video Gallery

 

 

5 Dariya News RNI Code: PUNMUL/2011/49000
© 2011-2024 | 5 Dariya News | All Rights Reserved
Powered by: CDS PVT LTD